Open Access
Open access
Drug Design, Development and Therapy, volume Volume 10, pages 3545-3553

Mimetics of brain-derived neurotrophic factor loops 1 and 4 are active in a model of ischemic stroke in rats

Gudasheva Tatyana A
Povarnina Polina
Logvinov Ilya O.
Seredenin Sergey B.
Publication typeJournal Article
Publication date2016-11-02
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor4.8
ISSN11778881
PubMed ID:  27843294
Drug Discovery
Pharmacology
Pharmaceutical Science
Abstract
Background Two dimeric dipeptides, bis-(N-monosuccinyl-l-seryl-l-lysine)hexamethylenediamide (GSB-106) and bis-(N-monosuccinyl-l-methionyl-l-serine) heptamethylenediamide (GSB-214), were designed based on the brain-derived neurotrophic factor (BDNF) loop 4 and loop 1 β-turn sequences, respectively. Earlier, both of these dipeptides were shown to exhibit neuroprotective activity in vitro (10−5–10−8 M). The present study aimed to investigate the mechanisms of action of these peptides and their neuroprotective activity in an experimental stroke model. Methods We used western blot and HT-22 hippocampal neuronal cell line to investigate whether these peptides induced phosphorylation of the TrkB receptor and the AKT and ERK kinases. Rat middle cerebral artery occlusion (MCAO) was used as a stroke model. GSB-106 and GSB-214 were administered intraperitoneally (0.1 mg (1.3×10−7 mol)/kg) 4 hours after MCAO and daily for 7 days. The cerebral infarct volumes were measured with 2,3,5-triphenyltetrazolium chloride staining 21 days after MCAO. Results Both compounds were shown to elevate the TrkB phosphorylation level while having different post-receptor signaling patterns. GSB-106 activated the PI3K/AKT and MAPK/ERK pathways simultaneously, whereas GSB-214 activated the PI3K/AKT only. In experimental stroke, the reduction of cerebral infarct volume by GSB-106 (∼66%) was significantly greater than that of GSB-214 (∼28% reduction), which could be explained by the fundamental role of the MAPK/ERK pathway in neurogenesis and neuroplasticity. Notably, between these two dipeptides, only GSB-106 exhibited antidepressant activity, as was found previously. Conclusion The results provided support for the beneficial pharmacological properties of BDNF loop 4 mimetic GSB-106, thereby suggesting a potential role for this dipeptide as a therapeutic agent.

Citations by journals

1
2
3
4
Doklady Biochemistry and Biophysics
Doklady Biochemistry and Biophysics, 4, 8.7%
Doklady Biochemistry and Biophysics
4 publications, 8.7%
Current Pharmaceutical Design
Current Pharmaceutical Design, 3, 6.52%
Current Pharmaceutical Design
3 publications, 6.52%
Bulletin of Experimental Biology and Medicine
Bulletin of Experimental Biology and Medicine, 3, 6.52%
Bulletin of Experimental Biology and Medicine
3 publications, 6.52%
Pharmacokinetics and Pharmacodynamics (Farmakokinetika i farmakodinamika)
Pharmacokinetics and Pharmacodynamics (Farmakokinetika i farmakodinamika), 3, 6.52%
Pharmacokinetics and Pharmacodynamics (Farmakokinetika i farmakodinamika)
3 publications, 6.52%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 2, 4.35%
International Journal of Molecular Sciences
2 publications, 4.35%
Pharmaceutical Chemistry Journal
Pharmaceutical Chemistry Journal, 2, 4.35%
Pharmaceutical Chemistry Journal
2 publications, 4.35%
European Neuropsychopharmacology
European Neuropsychopharmacology, 2, 4.35%
European Neuropsychopharmacology
2 publications, 4.35%
Neural Plasticity
Neural Plasticity, 1, 2.17%
Neural Plasticity
1 publication, 2.17%
JCI insight
JCI insight, 1, 2.17%
JCI insight
1 publication, 2.17%
CNS and Neurological Disorders - Drug Targets
CNS and Neurological Disorders - Drug Targets, 1, 2.17%
CNS and Neurological Disorders - Drug Targets
1 publication, 2.17%
Current Topics in Medicinal Chemistry
Current Topics in Medicinal Chemistry, 1, 2.17%
Current Topics in Medicinal Chemistry
1 publication, 2.17%
Доклады Академии наук
Доклады Академии наук, 1, 2.17%
Доклады Академии наук
1 publication, 2.17%
Brain Sciences
Brain Sciences, 1, 2.17%
Brain Sciences
1 publication, 2.17%
Cells
Cells, 1, 2.17%
Cells
1 publication, 2.17%
Pharmaceuticals
Pharmaceuticals, 1, 2.17%
Pharmaceuticals
1 publication, 2.17%
Frontiers in Neuroscience
Frontiers in Neuroscience, 1, 2.17%
Frontiers in Neuroscience
1 publication, 2.17%
Frontiers in Pediatrics
Frontiers in Pediatrics, 1, 2.17%
Frontiers in Pediatrics
1 publication, 2.17%
Scientific Reports
Scientific Reports, 1, 2.17%
Scientific Reports
1 publication, 2.17%
Journal of Molecular Neuroscience
Journal of Molecular Neuroscience, 1, 2.17%
Journal of Molecular Neuroscience
1 publication, 2.17%
Seminars in Cell and Developmental Biology
Seminars in Cell and Developmental Biology, 1, 2.17%
Seminars in Cell and Developmental Biology
1 publication, 2.17%
Neurochemistry International
Neurochemistry International, 1, 2.17%
Neurochemistry International
1 publication, 2.17%
Brain Research
Brain Research, 1, 2.17%
Brain Research
1 publication, 2.17%
Brain Research Bulletin
Brain Research Bulletin, 1, 2.17%
Brain Research Bulletin
1 publication, 2.17%
Pharmacology and Therapeutics
Pharmacology and Therapeutics, 1, 2.17%
Pharmacology and Therapeutics
1 publication, 2.17%
Journal of Cellular Physiology
Journal of Cellular Physiology, 1, 2.17%
Journal of Cellular Physiology
1 publication, 2.17%
Medicinal Research Reviews
Medicinal Research Reviews, 1, 2.17%
Medicinal Research Reviews
1 publication, 2.17%
Journal of Biomedical Science and Engineering
Journal of Biomedical Science and Engineering, 1, 2.17%
Journal of Biomedical Science and Engineering
1 publication, 2.17%
Bioorganic and Medicinal Chemistry
Bioorganic and Medicinal Chemistry, 1, 2.17%
Bioorganic and Medicinal Chemistry
1 publication, 2.17%
Obshchaya Reanimatologiya
Obshchaya Reanimatologiya, 1, 2.17%
Obshchaya Reanimatologiya
1 publication, 2.17%
Reviews on Clinical Pharmacology and Drug Therapy
Reviews on Clinical Pharmacology and Drug Therapy, 1, 2.17%
Reviews on Clinical Pharmacology and Drug Therapy
1 publication, 2.17%
1
2
3
4

Citations by publishers

1
2
3
4
5
6
7
8
9
Elsevier
Elsevier, 9, 19.57%
Elsevier
9 publications, 19.57%
Springer Nature
Springer Nature, 7, 15.22%
Springer Nature
7 publications, 15.22%
Bentham Science
Bentham Science, 5, 10.87%
Bentham Science
5 publications, 10.87%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 5, 10.87%
Multidisciplinary Digital Publishing Institute (MDPI)
5 publications, 10.87%
Pleiades Publishing
Pleiades Publishing, 5, 10.87%
Pleiades Publishing
5 publications, 10.87%
Publishing House OKI
Publishing House OKI, 3, 6.52%
Publishing House OKI
3 publications, 6.52%
Frontiers Media S.A.
Frontiers Media S.A., 2, 4.35%
Frontiers Media S.A.
2 publications, 4.35%
Wiley
Wiley, 2, 4.35%
Wiley
2 publications, 4.35%
Hindawi Limited
Hindawi Limited, 1, 2.17%
Hindawi Limited
1 publication, 2.17%
American Society for Clinical Investigation
American Society for Clinical Investigation, 1, 2.17%
American Society for Clinical Investigation
1 publication, 2.17%
The Russian Academy of Sciences
The Russian Academy of Sciences, 1, 2.17%
The Russian Academy of Sciences
1 publication, 2.17%
Scientific Research Publishing
Scientific Research Publishing, 1, 2.17%
Scientific Research Publishing
1 publication, 2.17%
V. A. Negovsky Research Institute of General Reanimatology
V. A. Negovsky Research Institute of General Reanimatology, 1, 2.17%
V. A. Negovsky Research Institute of General Reanimatology
1 publication, 2.17%
Eco-Vector LLC
Eco-Vector LLC, 1, 2.17%
Eco-Vector LLC
1 publication, 2.17%
Acta Naturae Ltd, 1, 2.17%
Acta Naturae Ltd
1 publication, 2.17%
1
2
3
4
5
6
7
8
9
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Gudasheva T. A. et al. Mimetics of brain-derived neurotrophic factor loops 1 and 4 are active in a model of ischemic stroke in rats // Drug Design, Development and Therapy. 2016. Vol. Volume 10. pp. 3545-3553.
GOST all authors (up to 50) Copy
Gudasheva T. A., Povarnina P., Logvinov I. O., Antipova T. A., Seredenin S. B. Mimetics of brain-derived neurotrophic factor loops 1 and 4 are active in a model of ischemic stroke in rats // Drug Design, Development and Therapy. 2016. Vol. Volume 10. pp. 3545-3553.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.2147/DDDT.S118768
UR - https://doi.org/10.2147%2FDDDT.S118768
TI - Mimetics of brain-derived neurotrophic factor loops 1 and 4 are active in a model of ischemic stroke in rats
T2 - Drug Design, Development and Therapy
AU - Gudasheva, Tatyana A
AU - Povarnina, Polina
AU - Logvinov, Ilya O.
AU - Antipova, Tatyana A
AU - Seredenin, Sergey B.
PY - 2016
DA - 2016/11/02 00:00:00
PB - Dove Medical Press
SP - 3545-3553
VL - Volume 10
PMID - 27843294
SN - 1177-8881
ER -
BibTex
Cite this
BibTex Copy
@article{2016_Gudasheva,
author = {Tatyana A Gudasheva and Polina Povarnina and Ilya O. Logvinov and Tatyana A Antipova and Sergey B. Seredenin},
title = {Mimetics of brain-derived neurotrophic factor loops 1 and 4 are active in a model of ischemic stroke in rats},
journal = {Drug Design, Development and Therapy},
year = {2016},
volume = {Volume 10},
publisher = {Dove Medical Press},
month = {nov},
url = {https://doi.org/10.2147%2FDDDT.S118768},
pages = {3545--3553},
doi = {10.2147/DDDT.S118768}
}
Found error?